VYT Stock Overview
Develops, produces, and sells active ingredients from plant stem cells for the cosmetic sector primarily in Spain.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Vytrus Biotech, S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.28 |
| 52 Week High | €2.60 |
| 52 Week Low | €1.78 |
| Beta | -0.023 |
| 11 Month Change | -1.72% |
| 3 Month Change | -5.79% |
| 1 Year Change | -4.20% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 5.56% |
Recent News & Updates
Shareholder Returns
| VYT | ES Personal Products | ES Market | |
|---|---|---|---|
| 7D | -3.4% | -0.3% | 1.3% |
| 1Y | -4.2% | 4.7% | 22.7% |
Return vs Industry: VYT underperformed the Spanish Personal Products industry which returned 4.7% over the past year.
Return vs Market: VYT underperformed the Spanish Market which returned 22.7% over the past year.
Price Volatility
| VYT volatility | |
|---|---|
| VYT Average Weekly Movement | 2.5% |
| Personal Products Industry Average Movement | 4.6% |
| Market Average Movement | 2.9% |
| 10% most volatile stocks in ES Market | 5.3% |
| 10% least volatile stocks in ES Market | 0.6% |
Stable Share Price: VYT has not had significant price volatility in the past 3 months.
Volatility Over Time: VYT's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 35 | Albert Font | www.vytrus.com |
Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells for the cosmetic sector primarily in Spain. It offers Nectaria Lithops, an active ingredient that biophysically optimizes the skin microenvironment and vitamin D levels; Photobiome a microbiota photoprotector; Olea Vitae cellular oil for ageing; Turmeria Zen for skin hydration and wrinkles on stressed profiles; Sensia Carota, a plant-based active that protects and prevents from the damage on sensitive and sensitized skins; Deobiome Noni, a biological deodorant; and Sarcoslim Re-Shape to reduce fat on tissue. The company also offers Capilia Longa for hair growth reactivation; Luminia Granatum for skin brightening;Elaya Renova a hair tensegrist; Kannabia Sense that stimulates the microbiota-skin-brain axis; Quora Noni to avoid the attack of skin harmful bacteria; Quora Noni biomics for rejuvenating the skin microbiota; Centella Reversa for facial complexion improvement; and Arabian Cotton for protection against photo-ageing.
Vytrus Biotech, S.A. Fundamentals Summary
| VYT fundamental statistics | |
|---|---|
| Market cap | €16.54m |
| Earnings (TTM) | €544.94k |
| Revenue (TTM) | €4.70m |
30.4x
P/E Ratio3.5x
P/S RatioIs VYT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VYT income statement (TTM) | |
|---|---|
| Revenue | €4.70m |
| Cost of Revenue | €354.66k |
| Gross Profit | €4.35m |
| Other Expenses | €3.80m |
| Earnings | €544.94k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.075 |
| Gross Margin | 92.46% |
| Net Profit Margin | 11.59% |
| Debt/Equity Ratio | 39.3% |
How did VYT perform over the long term?
See historical performance and comparison